146 related articles for article (PubMed ID: 3773723)
1. Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities.
Berger GM
Metabolism; 1986 Nov; 35(11):1054-61. PubMed ID: 3773723
[TBL] [Abstract][Full Text] [Related]
2. An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
Berger GM
Am J Clin Pathol; 1987 Sep; 88(3):369-73. PubMed ID: 3630977
[TBL] [Abstract][Full Text] [Related]
3. Hyperlipoproteinemia type I in a patient with active lipoprotein lipase in adipose tissue and indications of defective transport of the enzyme.
Fager G; Semb H; Enerbäck S; Olivecrona T; Jonasson L; Bengtsson-Olivecrona G; Camejo G; Bjursell G; Bondjers G
J Lipid Res; 1990 Jul; 31(7):1187-97. PubMed ID: 2205700
[TBL] [Abstract][Full Text] [Related]
4. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G
Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913
[TBL] [Abstract][Full Text] [Related]
5. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
Brunzell JD; Miller NE; Alaupovic P; St Hilaire RJ; Wang CS; Sarson DL; Bloom SR; Lewis B
J Lipid Res; 1983 Jan; 24(1):12-9. PubMed ID: 6833877
[TBL] [Abstract][Full Text] [Related]
6. Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
Kondo Y; Kurobane I; Omura K; Sano R; Abe R; Chida N; Tada K
Tohoku J Exp Med; 1985 Jan; 145(1):1-6. PubMed ID: 3983953
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase activity of adipose tissue, skeletal muscle and post-heparin plasma in primary endogenous hypertriglyceridaemia: relation to lipoprotein pattern and to obesity.
Taskinen MR; Nikkilä EA; Kuusi T
Eur J Clin Invest; 1982 Oct; 12(5):433-8. PubMed ID: 6816616
[TBL] [Abstract][Full Text] [Related]
8. Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Goldberg AP; Chait A; Brunzell JD
Metabolism; 1980 Mar; 29(3):223-9. PubMed ID: 7374436
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome.
Rouis M; Dugi KA; Previato L; Patterson AP; Brunzell JD; Brewer HB; Santamarina-Fojo S
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1400-6. PubMed ID: 9261273
[TBL] [Abstract][Full Text] [Related]
10. Effect of marginal zinc deficiency on lipoprotein lipase activities in postheparin plasma, skeletal muscle and adipose tissues in the rat.
Koo SI; Lee CC
Lipids; 1989 Feb; 24(2):132-6. PubMed ID: 2755301
[TBL] [Abstract][Full Text] [Related]
11. Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype.
Berger GM; Van der Westhuyzen JH; Huskisson J; Bonnici F; Henderson HE
S Afr Med J; 1982 Feb; 61(8):266-72. PubMed ID: 7058458
[TBL] [Abstract][Full Text] [Related]
12. Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Kern PA; Martin RA; Carty J; Goldberg IJ; Ong JM
J Lipid Res; 1990 Jan; 31(1):17-26. PubMed ID: 2313202
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
[TBL] [Abstract][Full Text] [Related]
14. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
15. Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia.
Schreibman PH; Arons DL; Saudek CD; Arky RA
J Clin Invest; 1973 Aug; 52(8):2075-82. PubMed ID: 4719678
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.
Wilson DE; Edwards CQ; Chan IF
Metabolism; 1983 Dec; 32(12):1107-14. PubMed ID: 6645961
[TBL] [Abstract][Full Text] [Related]
17. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.
Krauss RM; Levy RI; Fredrickson DS
J Clin Invest; 1974 Nov; 54(5):1107-24. PubMed ID: 4370795
[TBL] [Abstract][Full Text] [Related]
18. A newly identified lipoprotein lipase (LPL) gene mutation (F270L) in a Japanese patient with familial LPL deficiency.
Takagi A; Ikeda Y; Takeda E; Yamamoto A
Biochim Biophys Acta; 2000 Nov; 1502(3):433-46. PubMed ID: 11068186
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
Persson E
Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
[TBL] [Abstract][Full Text] [Related]
20. Adipose cell size and distribution in familial lipoprotein lipase deficiency.
Peeva E; Brun LD; Ven Murthy MR; Després JP; Normand T; Gagné C; Lupien PJ; Julien P
Int J Obes Relat Metab Disord; 1992 Oct; 16(10):737-44. PubMed ID: 1330953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
